Methods for neuroprotection

Details Methods for neuroprotection Methods for neuroprotection

1994-10-04

1996-09-10

Weddington, Kevin E.

Drug, bio-affecting and body treating compositions

Designated organic active ingredient containing

Cyclopentanohydrophenanthrene ring system doai

514181, A61K 3156

Patent

active

055546013

ABSTRACT:
A method is provided for conferring neuroprotection on a population of cells using estrogen compounds that have insubstantial sex activity and furthermore, a method is provided that utilizes estrogen compounds in the absence of testosterone for treating neurodegenerative diseases including Alzheimer's disease so as to retard the adverse effects of these disorders, Examples of estrogen compounds that have insubstantial sex activity includes alpha isomers of estrogen compounds such as 17.alpha. estradiol.

REFERENCES:
patent: 4897389 (1990-01-01), Aroonsakul
1976 Keller et al., Archives of Pharmacology 294:213-215.
1977 Perez-Polo et al., Life Sci. 21:1535-1543.
1980 Luine et al., Brain Research 191:273-277.
1982 Barde et al., EMBO J. 1:549-553.
1984 Fallon et al., Science 224:1107-1109.
1986 Morrison et al., Prc. Nat'l. Acad. Sci. U.S.A. 83:7537-7541.
1986 Morse et al., Experimental Neurology 94:649-658.
1986 Aizenman et al., Proc. Nat'l. Acad. Sci. U.S.A. 83:2263-2266.
1986 Fillet et al., Psychoneuroendocrinology 11:337-345.
1987 Morrison et al., Science 238:72-75.
1987 Monard, Biochem. Pharmacol. 36:1389-1392.
1987 Thoenen et al., Rev. Physiol. Biochem. Pharmacol. 109:145-178.
1987 Whittemore et al., J. Neurosci. 7:244-251.
1987 Baskin et al., Ann Rev. Physiol. 49:335-347.
1988 Derynck, Cell 54:161-170.
1988 Rosenberg et al., Science 242:1575-1578.
1988 Walicke, J. Neurosci. 8:2618-2627.
1988 Mouton et al., Brain Research 444:104-108.
1989 Stockli et al., Nature 342:920-923.
1989 Yamamori et al., Science 246:1412-1416.
1989 Oltersdorf et al., Nature 341:144-147.
1989 Whitson et al., Science 243:1488-1490.
1989 Hama et al., Neurosci. Lett. 104:340-344.
1989 Hefti et al., Neurobiol. Aging 10:515-533.
1989 Lin et al., Science 246:1023-1025.
1989 Honjo et al., Steroid Biochemistry 34:521-524.
1989 Gall et al., Science 245:758-761.
1990 Kovesdi et al., Biochem. Biophys. Res. Commun. 172:850-854.
1990 Kamegai, Neuron 2:429-436.
1990 Hohn et al., Nature 344:339-341.
1990 Fallon et al., Growth Factors 2:241-250.
1990 Spranger et al., Eur. J. Neurosci. 2:69-76.
1990 Maisonpierre et al., Neuron 5:501-509.
1990 Ernfors et al., Neuron 5:511-526.
1990 Rosenthal et al., Neuron 4:767-773.
1991 Hallbrook et al., Neuron 6:845-858.
1991 Berkemeier et al., Neuron 7:857-866.
1992 Woolley et al., Journal of Neuroscience 12:2549-2554.
1993 Gibbs et al., Society for Neuroscience Abstracts 19:5.
1987 Wright et al., Int. J. Dev. Neuroscience 5:305-311.
1988 Jones, Metabolic Brain Disease 3:1-18.
1992 Mizoguchi et al., Neuroscience Letters 138:157-160.
1992 Honjo et al., J. Steroid Biochem. Molec. Biol. 41:633-635.
1993 Emerson et al., Brain Research 608:95-100.
1955 Wroblewski et al., Proc. Soc. Exp. Biol. Med. 90:210-213.
1964 Black et al., Exp. Cell Research 35:9-13.
1970 Oldendorf, Brain Res. 24:37-46.
1971 Oldendorf, Am. J. Physiol. 221:1629-1638.
1975 Fonnum, J. Neurochem. 24:407-409.
1976 Kolbe et al., Biochemistry & Biophysics 73:378-382.

Affiliated with

Also associated with

Rating

Methods for neuroprotection does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Methods for neuroprotection, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Methods for neuroprotection will most certainly appreciate the feedback.

Rate now

Comments { 0 }

Profile ID: LFUS-PAI-O-1320497